HFNC KL-20

Fight the epidemic together

Novel Coronavirus pneumonia (NCP) is a pneumonia caused by SARS-CoV- infection. Severe and critically ill patients often have hypoxemia and dyspnea and proper respiratory support treatment is required.

As notel in the “ Expr Consensus on the use and management of HFNC for patients with Novel Coronavirus Pneumonia” , for acute hypoxic respiratory failure, high- flow nasal O2  therapy (HFNC) has greater advantages over conventional O2 therapy.

Simple and practical

  • Ultra Large touch screen: KL-20 is equipped with a 4.3 inch touch screen which allows easy and quick operation by touch and navigation knob.
  • Easy to set up flow rate and O2
  • Intuitive UI design: large font, easy for caregiver to operate and observe.

 

Safe and comfortable

  • Multi-position temp monitoring: KL-20 is equipped with 3 temp sensors, which enable real –tim monitoring, synchoronized closed- loop feedback, joint high temp alarm, smart water level management and over temp protection function to ensure safer heating.
  • High- performance nasal cannula: ergonomic design, soft and comfortable, free of constriction.
  • Ultra-quiet design: th ultra quiet turbine significantly reduces noise, provides a quiet O2 therapy environment, reduces irritability.